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Differentiation of endemic East African tick-borne re-
lapsing fever Borrelia duttonii spirochetes from epidemic 
louse-borne relapsing fever (LBRF) B. recurrentis spiro-
chetes into different species has been questioned. We as-
sessed a noncoding intragenic spacer (IGS) region to com-
pare genotypes found in clinical samples from relapsing 
fever patients. Although IGS typing was highly discrimina-
tory and resolved 4 East African tick-borne relapsing fever 
groups from a disease-endemic region in Tanzania, 2 IGS 
clades were found among LBRF patients in Ethiopia. The 2 
IGS sequence types for B. recurrentis overlapped with 2 of 
the 4 groups found among B. duttonii. All cultivable isolates 
of B. duttonii fell into a single IGS cluster, which suggests 
their analysis might introduce selective bias. We provide 
further support that B. recurrentis is a subset of B. duttonii 
and represents an ecotype rather than a species. These ob-
servations have disease control implications and suggest 
LBRF Borrelia spp. could reemerge from its tick-borne res-
ervoirs in which vectors coexist.
R
elapsing fever is a recurrent febrile infection caused 
by various Borrelia spirochetes transmitted either by 
lice (epidemic relapsing fever) or by ticks (endemic relaps-
ing fever). Relapsing fever was once a disease of global 
epidemic importance. However, largely as a result of the 
demise of the clothing louse Pediculus humanus, it is now 
restricted to areas where clothing lice are still common-
place, such as Ethiopia (1). In these regions it still has a 
major impact and was documented in a recent Ethiopian 
Department of Health report as being the seventh most 
common cause of hospital admission (2.5% of total; 3,777 
cases) and ﬁ  fth most common cause of death (0.9%, 42 
cases) (2004) (1). The epidemic tendency of this infection 
is likely to reside in its vector transmission, with waves of 
clothing lice ﬂ  eeing febrile patients and thus facilitating 
epidemic transmission. The endemic tick-borne relapsing 
fever spirochetes are transmitted by Ornithodoros ticks; O. 
sonrai serve as the principle vector for Borrelia crocidurae 
in West Africa, and O. moubata complex ticks effectively 
maintain these spirochetes in East Africa (1). Because soft 
ticks are only associated with hosts for their typically rapid 
nocturnal feeding, this limits the spread of infection beyond 
the conﬁ  nes of the areas where tick vectors reside.
Although these differing life styles of the vectors can 
account for the epidemiologic differences between these 
infections, recent studies have highlighted the similarity 
between B. recurrentis, the cause of louse-borne relapsing 
fever, and B. duttonii, the agent of East African of tick-
borne relapsing fever (2–4). It has been postulated that B. 
recurrentis is a louse-adapted variant of B. duttonii (5). 
In these disease-endemic regions, diagnosis is typically 
achieved through demonstration of spirochetes in stained 
blood ﬁ  lms from patients. However, this technique is un-
able to discriminate between the different Borrelia spp. that 
cause relapsing fever.
To provide a method able to reliably identify these 
spirochetes, we validated the use of sequence analysis of 
an intragenic spacer (IGS) region for typing these spiro-
chetes (3). This method was used to analyze a noncoding 
spacer region and proved to be highly discriminatory; it 
resolved 4 groups among B. duttonii found among iso-
lates and directly in tick vectors. Two groups were found 
among B. recurrentis isolates and louse vectors (3). Fur-
thermore, a novel Borrelia species detected previously 
was found, and some sequence types resembled B. croci-
durae, previously believed to be only in West Africa (3,6). 
The surprising ﬁ  nding was that 1 phylogenetic group of 
B. duttonii overlapped with a group of B. recurrentis (3). 
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This colinearity was further supported by complete ge-
nomic sequencing of 1 isolate of B. recurrentis and 1 of B. 
duttonii, which suggests that B. recurrentis is a decaying 
genome that evolved from either B. duttonii or a common 
ancestral strain (5).
To further explore this apparent overlap between B. 
duttonii and B. recurrentis, we sequenced and compared 
additional gene targets. However, this study focused upon 
coding genes that were under different selective pressure 
and thus were not necessarily comparable to the noncod-
ing IGS previously used. Furthermore, these investigations 
used only cultivable strains, and thus could represent bias 
toward those able to grow under axenic conditions. These 
investigations disclosed a clear demarcation between B. 
duttonii and B. recurrentis (4).
To resolve this apparent dichotomy, we undertook ad-
ditional IGS typing directly on serum samples collected 
from patients with clinical cases, thus removing the selec-
tive pressure of cultivation. We report the results of those 
investigations.
Materials and Methods
Clinical Samples
Eighty-eight serum samples from patients in Ethiopia 
with relapsing fever that were blood ﬁ  lm–positive for spi-
rochetes were collected and stored frozen at –20°C before 
testing. Similarly, 23 samples collected from patients in 
Tanzania were collected and stored frozen. An additional 
series of 45 samples from family members accompanying 
patients to hospital as potential blood donors were available 
for analysis. Ethical approval for their collection and test-
ing for relapsing fever had been granted for earlier studies 
(Ethiopia [7] and Commission for Science and Technology 
[COSTECH] 2001–330-NA-2001–25 for Tanzania).
DNA Extraction
Serum samples were centrifuged at 13,000 rpm in a 
microfuge for 30 min and 100 μL of the pellet was used for 
DNA extraction. After an initial proteinase K digestion in a 
waterbath at 56°C for 1 h, DNA extraction was conducted 
by using DNeasy reagents (QIAGEN, Valencia, CA, USA) 
according to the manufacturer’s protocol for the QIAcube 
robotic platform with a ﬁ  nal elution volume of 200 μL.
Preliminary Screening for Borrelia spp.
A real-time TaqMan ﬂ  agellin assay was used to screen 
samples for the presence of borrelial DNA before inves-
tigation. The primers are shown in Table 1. Primers were 
used at a ﬁ  nal concentration of 1,000 mmol/L, and the 
probe was used at a ﬁ  nal concentration of 50 mmol/L. A 
mastermix composed of PCR working concentration buf-
fer without MgCl2 (Invitrogen, Carlsbad, CA, USA), 0.2 
mmol/L of each dNTP, 5 mmol/L MgCl2, 0.075 nmol/L 
Rox, and 0.06 U Taq polymerase (Invitrogen). Master-
mix was divided into aliquots of 23 μL to which 2 μL 
of extracted DNA was added. A MX3000 thermocycler 
(Stratagene, La Jolla, CA, USA) was used with an initial 
denaturation of 95°C for 10 min, followed by 50 cycles 
each at 94°C for 15 s and 60°C for 60 s. Results were read 
at a Fam wavelength (emission 516) by using Rox as a 
reference wavelength (emission 610).
IGS Typing
Samples positive for Borrelia DNA by the ﬂ  agellin 
real-time assay were further subjected to IGS typing. A 
nested PCR was used to amplify the IGS, with outer prim-
ers anchored within the 3′ end of the rrs ribosomal gene 
and the 5′ end within the ileT gene as used previously (3). 
Primer sequences are shown in Table 1. Conventional PCR 
was performed by using 25-μL reaction volumes in My 
Cycler thermocylers (Bio-Rad, Hercules, CA, USA) with 
an initial denaturation at 94°C for 3 min, followed by 35 
cycles at 94°C for 30 s, 55°C for 30 s, and 74°C for 60 s, 
and a ﬁ  nal extension at 72°C for 7 min. A 2-μL volume 
from the ﬁ  rst-round reaction was added to 23 μL of fresh 
second-round mastermix. This mixture was heated at 94°C 
for 3 min, followed by 35 cycles at 94°C for 30 s, 60°C for 
30 s, and 74°C for 60 s, and a ﬁ  nal extension at 72°C for 7 
min. Resulting amplicons were resolved by electrophoresis 
on 1% agarose gels stained with ethidium bromide (0.5 μg/
mL). Different manipulations of the PCR were conducted 
in different laboratory areas to avoid contamination, and 
nontemplate controls were included at a ratio of 1 for every 
15 samples tested.
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Table 1. Primer and probe sequences used in study of East African relapsing fever Borrelia spp.*  
Primer specificity  Primer/probe sequence, 5ƍ o 3ƍ 
Flagellin forward  CTAGTGGGCATAGAATTAATCGTGC 
Flagellin reverse  GCTTGGGATAACCCTCTAATTTGA 
Flagellin probe  fam-TGGTATGGGTGTTGCTGGGAAAATTACG-bhq1 
First-round IGS forward  GTATGTTTAGTGAGGGGGGTG 
First-round IGS reverse  GGATCATAGCTCAGGTGGTTAG 
Second-round IGS forward  AGGGGGGTGAAGTCGTAACAAG 
Second-round IGS reverse  GTCTGATAAACCTGAGGTCGGA 
*IGS, intragenic spacer. RESEARCH
Sequencing and Phylogenetic Analysis
Resulting amplicons were subjected to sequence anal-
ysis on an ABI 3700 automated DNA sequencer (Applied 
Biosystems, Foster City, CA, USA) at the Genome Centre 
Queen Mary’s University, London. The inner nested prim-
ers were additionally used for sequencing primers at a con-
centration of 10 pmol/μL. Sequence results were aligned by 
using ClustalW (www.ebi.ac.uk/clustalw) trimmed and a 
neighbor-joining phylogenetic tree was constructed by us-
ing MEGA4 (8).
Results
Most samples collected from patients with either louse-
borne (all 88 serum samples) or tick-borne relapsing fever 
(21/23 samples), yielded a positive PCR result upon ini-
tial screening and subsequently when tested for IGS. The 
2 samples positive by initial microscopy, but negative by 
PCR, may represent DNA degradation over the prolonged 
period of frozen storage before testing. Additionally, 15 of 
45 blood donors who accompanied patients in Tanzania 
had positive test results upon screening; samples from 9 of 
these also produced IGS amplicons. Nontemplate controls 
showed negative results.
IGS sequence data were obtained for 90% of the 124 
PCR screen–positive samples (18 from patients with tick-
borne relapsing fever, 85 from patients with louse-borne 
relapsing fever, and 9 from blood donors in Tanzania) and 
used for phylogenetic analysis. Only 5 of the 34 identical 
B. recurrentis type I sequences (represented by B. recur-
rentis A1 DQ000277) and 7 of the 43 B. recurrentis type II 
sequences (represented by B. recurrentis A11 DQ000278) 
are shown in Figure.
Similar to results found when looking at cultivable 
strains and IGS data in ticks or lice (3), we were able to 
show 4 clades among B. duttonii and 2 for B. recurrentis 
(Figure). Two of the B. duttonii clades contained only se-
quence types from patients in Tanzania or blood donors. 
Notably, all of the cultivable strains of B. duttonii resem-
bled sequence type I. The other previously designated type 
IV (3), represented by B. duttonii WM (DQ000282) that had 
been represented by a single patient sequence, was found in 
2 additional patient samples and in 1 serum sample from a 
blood donor. The remaining 2 B. duttonii clades overlapped 
with the 2 B. recurrentis clades. The accession numbers for 
the sequences types shown in Figure are deposited under 
GenBank nos. GQ401243–GQ401278 (Table 2). 
Discussion
The ﬁ  ndings of this study build upon those previously 
reported (3). As before, on the basis of IGS sequence types, 
we identiﬁ  ed 4 distinct clusters of B. duttonii. Thus, the 
ﬁ  ndings of this study, which analyzed sequence types in 
clinical samples, generally mirror results found when in-
vestigating sequence types of bacteria in arthropod vectors 
(3). The notable exception to this was the absence of the 
novel Borrelia sp. previously detected by Scott et al. in 
ticks (3) and by others in ticks and human samples (6,9). 
Whether detection of this species in humans with fever 
was directly related to the fever or incidental remains to 
be assessed through properly structured epidemiologic in-
vestigations. We did not detect this species among samples 
collected from patients with clinical relapsing fever in our 
study population. In consequence, our ﬁ  ndings do not sup-
port the conclusion that this species has the potential to 
cause human infection.
Our samples from Tanzania were collected from villag-
ers living in traditional mud-built dwellings; these dwell-
ings usually have >80% infestation rates with O. moubata 
ticks. Regular nocturnal feeding by ticks could account 
for efﬁ  cient transmission of these spirochetes to humans. 
Consequently, it is not surprising that samples from these 
persons, or from the asymptomatic blood donors who lived 
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Figure. Phylogenetic tree of intragenic space sequences showing 2 
groups among Borrelia recurrentis and 4 groups among B. duttonii. 
Tree created by using the unweighted pair group method with 
arithmetic mean. The B. recurrentis groups overlap with B. duttonii 
groups. Scale bar indicates nucleotide substitutions per site. Tz, 
Tanzania.East African Relapsing Fever Borrelia spp.
in similar conditions, were positive for B. duttonii. The 
absence of evidence of cross-contamination of the assays 
further substantiates these ﬁ  ndings. Others have reported 
microscopy positive samples and PCR positive results from 
asymptomatic persons in Tanzania (6), which lends further 
support to this ﬁ  nding. Whether these observations repre-
sent persistent infection, as seen in the related spirochete 
that causes Lyme borreliosis, or reﬂ  ects continued expo-
sure by feeding ticks, remains to be elucidated.
Conversely, in Ethiopia, data are not available con-
cerning the prevalence of soft tick species; however, infes-
tation with clothing lice is commonplace (10). Based on the 
vector prevalence, in Ethiopia, relapsing fever has always 
been presumed to result from B. recurrentis infection. A 
subset of serum samples included in the current study were 
found to harbor a premature stop codon in their recA gene 
(S.J. Cutler et al., unpub. data), a feature disclosed in B. 
recurrentis, but not B. duttonii, in the recently completed 
whole genome sequencing of these spirochetes (5). This 
ﬁ  nding provides further evidence for the identiﬁ  cation of 
infecting spirochetes among these samples.
The distribution of IGS proﬁ  les found among Tanza-
nian blood donors did not appear to differ from that found 
among persons with clinical cases in this region. The ap-
parent absence of associated clinical signs is likely to cor-
relate with a degree of local immunity. This ﬁ  nding is the 
basis of much local folk lore on the need to have regular 
tick exposure to boost immunity (11). These spirochetes 
undergo multiphasic antigenic variation (12), and whether 
they would continue to cause asymptomatic infection if the 
spirochetes underwent antigenic variation remains specula-
tive. Furthermore, these organisms are able to evade key 
components of the innate immune response (13). This eva-
sion might help account for their presence in asymptomatic 
persons.
Strikingly, the IGS sequence type for the cultivable 
isolates obtained for B. duttonii all fell into a single clade 
in which only B. duttonii sequence types were represented. 
This ﬁ  nding would explain the distinct clustering previous-
ly reported that separated B. duttonii from B. recurrentis 
when a multigene sequence–based approach was used (4). 
It may be that this particular cluster of B. duttonii is more 
readily cultivable that those belonging to other clades, thus 
highlighting the potential for misinterpretation of popula-
tion structure analysis that is based only on cultivable iso-
lates.
We had reported that B. recurrentis fell into 2 clades, 
which we can reconﬁ  rm with our current in situ ﬁ  ndings 
(3). Of the samples tested from patients in Ethiopia with 
louse-borne relapsing fever, 44% fell into the type I clade 
and 56% were type II. Interestingly, our earlier work 
showed that B. duttonii type II represented by tick sample 
MA/15 (DQ000280) had a IGS sequence identical to those 
found for B. recurrentis type I from Ethiopia. Our current 
ﬁ  ndings have provided further support for this observation 
by showing that another B. duttonii type III represented 
by tick sample MA/18 (DQ000281) aligns more closely 
with B. recurrentis IGS types. Further examples of IGS 
sequence homology were found between spirochetes that 
cause louse-borne relapsing fever and those that cause tick-
borne relapsing fever, in samples from 2 patients from Tan-
zania with tick-borne relapsing fever (Bd4 and Bd14) and 
also from 2 blood donors from Tanzania (Tz blood donor 6 
and Tz blood donor 19); the isolates clustered among B. 
recurrentis type II.
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Table 2. Sample designation and accession numbers for Borrelia 
recurrentis and B. duttonii, East Africa 
Strain designation  Species
GenBank
accession no. Reference
Bd11 B. duttonii GQ401243 This study
Bd9 B. duttonii GQ401244 This study
Tz blood donor 1 B. duttonii GQ401245 This study
SJC4 B. recurrentis GQ401246 This study
Br5 B. recurrentis GQ401247 This study
Br8 B, recurrentis GQ401248 This study
Br9 B. recurrentis GQ401249 This study
Tz blood donor 6 B. duttonii GQ401250 This study
Tz blood donor 19 B. duttonii GQ401251 This study
SJC13 B. recurrentis GQ401252 This study
Br2 B. recurrentis GQ401253 This study
Br3 B. recurrentis GQ401254 This study
Tz blood donor 2 B. duttonii GQ401255 This study
Tz blood donor 20 B. duttonii GQ401256 This study
Tz blood donor 4 B. duttonii GQ401257 This study
Bd2 B. duttoii GQ401258 This study
Bd3 B. duttonii GQ401259 This study
Bd7 B. duttonii GQ401260 This study
Bd10 B. duttonii GQ401261 This study
Bd14 B. duttonii GQ401262 This study
SJC1 B. recurrentis GQ401263 This study
Br1 B. recurrentis GQ401264 This study
Br10 B. recurrentis GQ401265 This study
Br12 B. recurrentis GQ401266 This study
Bd8 B. duttonii GQ401267 This study
Bd6 B. duttonii GQ401268 This study
Bd5 B. duttonii GQ401269 This study
Bd4 B. duttonii GQ401270 This study
Bd14 B. duttonii GQ401271 This study
Bd19 B. duttonii GQ401272 This study
Bd18 B. duttonii GQ401273 This study
Bd15 B. duttonii GQ401274 This study
Bd12 B. duttonii GQ401275 This study
Bd13 B. duttonii GQ401276 This study
Bd1 B. duttonii GQ401277 This study
Br7 B. recurrentis GQ401278 This study
A1 B. recurrentis DQ000277 (3)
A11 B. recurrentis DQ000278 (3)
Ly B. duttonii DQ000279 (3)
MA15 B. duttonii DQ000280 (3)
MA18 B. duttonii DQ000281 (3)
WM B. duttonii DQ000282 (3)RESEARCH
The vectorial speciﬁ  city of these spirochetes has been 
a source of curiosity for many years. Early investigations 
questioned host and vector speciﬁ  cities of relapsing fever 
spirochetes; studies were carried out that enabled ticks to 
feed on patients with the louse-borne form of the disease 
and subsequently letting these ticks feed upon nonfebrile 
persons. These studies were unable to conclusively estab-
lish whether alternative arthropod vectors could transmit 
these spirochetes. Haberkorn demonstrated that B. crocidu-
rae isolated from O. erraticus successfully multiplied in lice 
(14). The investigations by Heisch and Garnham initially 
claimed successful transmission of B. duttonii by body lice 
(15). However, in a later study Heisch concluded that B. 
duttonii from humans is unlikely to be naturally transmit-
ted by lice (16). Many of these early investigations were 
hampered by the inability to reliably identify the organisms 
used, lack of cultivable strains, and having no means of as-
sessing the immune status of recipient hosts. Speciation of 
the causative relapsing fever spirochete was based on the 1 
vector–1 species criteria that relied on geographic region 
where infection occurred and identiﬁ  cation of the vector 
responsible for transmission.
Collectively, these ﬁ  ndings support the increasing evi-
dence that B. recurrentis has evolved either directly from 
B. duttonii or from a common ancestral strain. This raises 
the question of whether these spirochetes should be con-
sidered as separate species or as ecotypes of the same spe-
cies? With the advent of molecular typing tools, should the 
traditional classiﬁ  cation of relapsing fever spirochetes be 
readdressed? A precedent for this approach already exists 
with other highly related organisms such as Bacillus an-
thracis, B. cereus, and B. thuringiensis (17). Although IGS 
typing provides a highly discriminatory tool to type these 
spirochetes, these observations should be underpinned by 
sequence analysis of multiple gene targets to provide a ro-
bust phylogenetic analysis.
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